Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

7 Oct 2022

Abstract excerpt

PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and gene-expression data were analyzed to identify prognostic and diagnostic features. EXPERIMENTAL DESIGN:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36222710
DOI: 10.1158/1078-0432.ccr-22-1206

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesPMID 36222710Read ↗

The molecular origin and taxonomy of mucinous ovarian carcinomaSemantic proximity Read ↗

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian CancerSemantic proximity Read ↗

A distinct molecular profile associated with mucinous epithelial ovarian cancer.Semantic proximity Read ↗

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalSemantic proximity Read ↗

Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patientsSemantic proximity Read ↗

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentSemantic proximity Read ↗

Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratificationSemantic proximity Read ↗

Analyzing the extracellular matrix-dominated immune landscape of high-grade serous ovarian cancer to determine prognosis and guide therapySemantic proximity Read ↗

Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironmentSemantic proximity Read ↗

Integrated Bioinformatical Analysis for Identification the invasion-related Genes in ovarian cancerSemantic proximity Read ↗

Efficient molecular subtype classification of high‐grade serous ovarian cancerSemantic proximity Read ↗

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.